Immunohistochemistry practices of cytopathology laboratories: A survey of participants in the college of American pathologists nongynecologic cytopathology education program

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 9, 2014, Pages 1167-1172

  Fischer, Andrew H ^a   Schwartz, Mary R ^b   Moriarty, Ann T ^c   Wilbur, David C ^d   Souers, Rhona ^e   Fatheree, Lisa ^e   Booth, Christine N ^f   Clayton, Amy C ^g   Kurtyz, Daniel F I ^h   Padmanabhan, Vijayalakshmi ⁱ   Crothers, Barbara A ^j  

^a University of Massachusetts   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Ameripath Inc   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e North Carolina   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g MAYO CLINIC   (United States)

^h WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

ⁱ DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^j WALTER REED ARMY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CYTOLOGY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; LABORATORY; MEDICAL EDUCATION; MOLECULAR PATHOLOGY; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; PROTO ONCOGENE; QUESTIONNAIRE; STANDARDS;

ADENOCARCINOMA; CYTOLOGICAL TECHNIQUES; DATA COLLECTION; EDUCATION, MEDICAL, CONTINUING; GENES, ERBB-2; GUIDELINES AS TOPIC; HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORIES; PATHOLOGY, CLINICAL; PATHOLOGY, MOLECULAR; QUESTIONNAIRES;

EID: 84907192426     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0259-CP     Document Type: Article

References (30)

1. Kirbis IS, Maxwell P, Fle?zar MS, Miller K, Ibrahim M. External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results. Cytopathology. 2011;22(4):230-237.
2. Skoog L, Tani E. Immunocytochemistry: an indispensable technique in routine cytology. Cytopathology. 2011;22(4):215-229.
3. Schmitt F, Barroca H. Role of ancillary studies in fine-needle aspiration from selected tumors. Cancer Cytopathol. 2011;120(3):145-160.
4. Fowler LJ, Lachar WA. Application of immunohistochemistry to cytology. Arch Pathol Lab Med. 2008;132(3):373-383.
5. Roh MH, Schmidt L, Placido J, et al. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma. Diagn Cytopathol. 2012; 40(11):949-955.
6. Gong Y, Sun X, Michael CW, Attal S, Williamson BA, Bedrossian CWM. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrept vs. cell block. Diagn Cytopathol. 2003;28(1):1-5.
7. Zhang Z, Zhao L, Guo H, Pan Q, Sun Y. Diagnostic significance of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Diagn Cytopathol. 2012;40(12):1071-1076.
8. Hansen T, Pedersen H, Brauner V, Hariri J. Control specimens for immunocytochemistry in liquid-based cytology. Cytopathology. 2011;22(4): 243-246.
9. Maleki S, Dorokhova O, Sunkara J, Schlesinger K, Suhrland M, Oktay MH. Estrogen, progesterone, and HER-2 receptor immunostaining in cytology. Diagn Cytopathol. 2013;41(10):864-870.
10. Gong Y, Joseph T, Sneige N. Validation of commonly used immunostains on cell-transferred cytologic specimens. Cancer. 2005;105(3):158-164.
11. Elsheikh TM, Corbin K. Validation of commonly used immunostains on cell-transferred cytologic specimens. Cancer. 2006;108(2):135-136; author reply 136.
12. Hanley KZ, Birdsong GG, Cohen C, Siddiqui MT. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas. Cancer Cytopathol. 2009;117(4):279-288.
13. Wagner DG, Russell DK, Benson JM, Schneider AE, Hoda RS, Bonfiglio TA. CellientTM automated cell block versus traditional cell block preparation: a comparison of morphologic features and immunohistochemical staining. Diagn Cytopathol. 2011;39(10):730-736.
14. Gorman BK, Kosarac O, Chakraborty S, Schwartz MR, Mody DR. Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin. Acta Cytol. 2012; 56(3):289-296.
15. van Hemel BM, Suurmeijer AJ. Effective application of the methanol-based PreservCytTM fixative and the CellientTM automated cell block processor to diagnostic cytopathology, immunocytochemistry, and molecular biology. Diagn Cytopathol. 2013;41(8):734-741.
16. Anatomic pathology checklist: CAP Accreditation Program. College of American Pathologists Web site. http://www.cap.org/apps/docs/laboratory-accreditation/checklists/new/anatomic-pathology-checklist.pdf. Accessed November 20, 2013.
17. Wolff AC, Hammond MEH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-145.
18. Schmitt F, Cochand-Priollet B, Toetsch M, Davidson B, Bondi A, Vielh P. Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry. Cytopathology. 2011;22(4):238-242.
19. Colasacco C, Mount S, Leiman G. Documentation of immunocytochemistry controls in the cytopathologic literature: a meta-analysis of 100 journal articles. Diagn Cytopathol. 2010;39(4):245-250.
20. NordiQC immunohistochemistry quality control for pan keratin. NordiQC Web site. http://www.nordiqc.org/Run-36-B14-H2/Assessment/assessment-36-CK-PAN.htm. Accessed November 20, 2013.
21. NordiQC immunohistochemistry quality control for PAX8. NordiQC Web site. http://www.nordiqc.org/Run-34/Assessment/assessment-34-PAX8.htm. Accessed November 20, 2013.
22. Paik S, Bryant J, Tan-Chiu E, et al. Real-world performance of HER2 testing- National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst. 2002;94(11):852-854.
23. Perez EA, Suman VJ, Davidson NE, et al. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol. 2006;24(19):3032-3038.
24. Roche PC, Suman VJ, Jenkins RB, et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst. 2002;94(11):855-857.
25. Gelber RD, Gelber S. Facilitating consensus by examining patterns of treatment effects. Breast. 2009;18(suppl 3):S2-S8.
26. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134(7):e48-e72.
27. Wolff AC, Hammond MEH, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update [published online ahead of print October 7, 2012]. Arch Pathol Lab Med. 2014;138(2):241-256.
28. Fischer AH, Savas L, Smith K, et al. Validation of Cellient-type processing of FNA's without formalin for Her2/Neu testing. Cancer Cytopathol. 2008; 114(suppl 5):351.
29. Hardy LB, Fitzgibbons PL, Goldsmith JD, et al. Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories. Arch Pathol Lab Med. 2013;137(1):19-25.
30. Kurtycz DF, Logrono R, Leopando M, Slattery A, Inhorn SL. Immunocytochemistry controls using cell culture. Diagn Cytopathol. 1997;17(1):74-79.